Aurora Cannabis Inc. (NASDAQ:ACB – Free Report) – Analysts at Atb Cap Markets increased their Q3 2025 earnings per share (EPS) estimates for Aurora Cannabis in a report issued on Wednesday, November 6th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings per share of ($0.09) for the quarter, up from their previous forecast of ($0.16). The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.02) per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ Q4 2025 earnings at ($0.06) EPS, FY2025 earnings at ($0.02) EPS, FY2026 earnings at ($0.03) EPS, FY2027 earnings at ($0.05) EPS, FY2028 earnings at $0.18 EPS and FY2029 earnings at $0.84 EPS.
Aurora Cannabis Stock Performance
NASDAQ ACB opened at $4.78 on Monday. The stock has a fifty day simple moving average of $5.61 and a 200-day simple moving average of $5.95. The company has a current ratio of 3.83, a quick ratio of 2.03 and a debt-to-equity ratio of 0.07. The stock has a market cap of $262.14 million, a PE ratio of -6.29 and a beta of 1.87. Aurora Cannabis has a twelve month low of $2.84 and a twelve month high of $9.35.
Institutional Inflows and Outflows
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
- Five stocks we like better than Aurora Cannabis
- Transportation Stocks Investing
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- The Role Economic Reports Play in a Successful Investment Strategy
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.